Association of CYP19 Gene Polymorphism with Vertebral Fractures in Japanese Postmenopausal Women

[1]  新井 誠二.  New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry , 2010 .

[2]  S. Cummings,et al.  Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. , 2009, The Journal of clinical endocrinology and metabolism.

[3]  D. Altshuler,et al.  Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. , 2007, Cancer research.

[4]  S. Olson,et al.  Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. , 2007, American journal of epidemiology.

[5]  Xiping Xu,et al.  CYP19A1 polymorphisms are associated with bone mineral density in Chinese men , 2007, Human Genetics.

[6]  S. Kardia,et al.  Aromatase gene (CYP 19) polymorphisms and endogenous androgen concentrations in a multiracial/multiethnic, multisite study of women at midlife. , 2006, The American journal of medicine.

[7]  A. Díez-Pérez,et al.  A new SNP in a negative regulatory region of the CYP19A1 gene is associated with lumbar spine BMD in postmenopausal women. , 2006, Bone.

[8]  J. Riancho,et al.  Aromatase gene and osteoporosis: relationship of ten polymorphic loci with bone mineral density. , 2005, Bone.

[9]  R. Eastell,et al.  Long-term effects of aromatase inhibitors on bone , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  E. Simpson,et al.  Aromatase expression in the human fetal osteoblastic cell line SV-HFO. , 2004, Journal of molecular endocrinology.

[11]  B. Ponder,et al.  Polymorphisms associated with circulating sex hormone levels in postmenopausal women. , 2005, Journal of the National Cancer Institute.

[12]  S. Ralston,et al.  Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women. , 2004, The Journal of clinical endocrinology and metabolism.

[13]  C. Schneeberger,et al.  Production and actions of estrogens. , 2002, The New England journal of medicine.

[14]  M. Brandi,et al.  Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. , 2001, The Journal of clinical endocrinology and metabolism.

[15]  K. Toda,et al.  Sex- and age-related response to aromatase deficiency in bone. , 2001, Biochemical and biophysical research communications.

[16]  J. Zerwekh,et al.  Bone Has a Sexually Dimorphic Response to Aromatase Deficiency , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  H. Pols,et al.  Estradiol formation by human osteoblasts via multiple pathways: Relation with osteoblast function , 1999, Journal of cellular biochemistry.

[18]  E. Simpson,et al.  Aromatase expression of human osteoblast-like cells , 1998, Molecular and Cellular Endocrinology.

[19]  S. Bulun,et al.  Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. , 1994, The Journal of clinical endocrinology and metabolism.

[20]  N. Harada,et al.  Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Mendelson,et al.  Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. , 1993, The Journal of biological chemistry.